Sensori Healthcare and HomePal Sign Strategic Agreement for Technology Validation

On November 29, 2024, Hong Wei CHEN, CEO, HomePal Technologies, and Dr. Bo Wang, CEO, SENSORI Healthcare, officially signed a Technology Validation Partnership Agreement at Curie, Singapore. Both of the companies are supported by NUS. They are recipients of the coveted NUS Graduate Research Innovation Programme (GRIP) Grant Awards.

Strategically, the two promising deeptech startups aim to integrate their patented technologies, to create a comprehensive health monitoring solution for longterm care environments. This agreement marks a significant milestone, paving the way to achieve significant synergies between remote health monitoring and intelligent care solutions.

HomePal Technologies provides contactless AI-powered monitoring solutions for elderly care in facilities and homes. Currently, their sensor fusion technology helps nursing homes prevent bedside falls while preserving privacy. The system enhances senior safety and supports caregivers in delivering more efficient care across various settings.

SENSORI Healthcare provides intelligent health monitoring solutions. Embracing a patient-centric ethos, a data-driven and an evidenced based AI powered platform, Sensori prioritizes medical values based on efficacy and safety. We aims to accelerate the development of the next generation of a contactless, continuous and simultaneous monitoring of key vital signs devices.